medigraphic.com
Instituto Nacional de Salud Pública

2005, Number 5

Next >>

salud publica mex 2005; 47 (5)

Letters to the editor

Cardozo GR

Language: Spanish
References: 57
Page: 325-326
PDF size: 85.62 Kb.


Text Extraction

No Abstract


REFERENCES

  1. World Health Organization. What is DOTS. A guide to understanding the WHO- recommended

  2. TB Control Strategy Known as DOT. Ginebra: WHO (WHOICDS/CPC/TB/99.270), 1999.

  3. Reigota R M S. A valiação do controle da tuberculose pulmonar no município de Bauru -

  4. SP implantayao do tratamento supervisionado, 1999/2000. Tesis. Botucatu (SP): Esco1a de

  5. Enfermagem de Ribeirão Preto/USP, 2001.

  6. Pinho J L , Nogueira P A. Tratamento supervisionado em tuberculose no município de

  7. Taboão da Serra, Sao Paulo 1998-1999. Bol Pneumol Sanitaria (Rio de Janeiro) 2001; 9(1):

  8. 13-18.

  9. World Health Organization.Global tuberculosis control - surveillance, planning,

  10. financing. WHO Report 2004 [monografía en internet]. Ginebra: WHO, 2004 [consultado

  11. 2004 abril 5]. Disponible en: http://www.who.intltb/publications/globalreport/2004/enlBrazil.pdf

  12. Morse D. Directly observed therapy for tuberculosis. BMJ 1996; 312: 719-720.

  13. OPS. Programas Nacionales de Control de TB. México, D.F.: Oficina Regional de la OMS.

  14. (OPS/HCP/HCT176/00), 2000.

  15. Lee E T. Statistical method for survival data analysis. Nueva York: John Wiley & Sons, 1992.

  16. Ministério da Saúde. Manual Técnico para o Controle da Tb 2002. Brasília (D.F.): Ministério da Saúde; Caderno de Atenção Básica No. 6), 2002.

  17. Frieden T, Driver C. Tuberculosis control: Past 10 years and future progress. J Tuberculosis 2003; 83 (issues 1-3):82-85.

  21. Secretaría de Salud. Dirección General de Epidemiología. Histopathological Registry of

  22. Malignant. México, D.F.: SSA, 1996.

  23. Fu YS, Reagan JW, Richart RM. Definition of precursors. Gynecol Oncol 1981;12:220-231.

  24. WHO. Infecciones genitales por papilomavirus humanos y cáncer: memorándum de una

  25. reunión de la OMS. Bol Oficina Sanit Panam 1987;65:120-137.

  26. Ludicke F, Stalberg A, Vassilakos P, Major AL, Campana A. High-and intermediate-risk human papillomavirus infection in sexually active adolescent females. J Pediatr Adolesc Gynecol 2001;14(4):171-174.

  27. Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-González CJ, Zampilpa-Mejía LG,

  28. García Cisnseros S et al. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers frm Mexico City. Sex Transm Dis. 2001;28(3):125-130.

  29. Rodríguez-Reyes ER, Cerda-Flores RM, Solís-Rios NP, Quiñones-Pérez JM, Cortés-Gutiérrez EI. Identification and typification of the human papiloma virus in women using the “Timely Detection of Cancer” program in Durango, Mexico. Ginecol Obsted Mex. 2003;71:471-475.

  30. Mak R, Van Renterghen L, Cuvelier C. Cervical smears and human papillomavirus

  31. typing in sex workers. Sex Transm Infect 2004;80:(2)118-120.

  32. Chan R, Khoo L, Ho TH, Koh CF, Lee ILU, Yam KL et al. A comparative study of cervical

  33. cytology, colposcopy and PCR for HPV in female sex workers in Singapore. Int J STD

  34. AIDS. 2001;12(3):159-163.

  35. Tideman RL, Thompson C, Rose B, Gilmour S, Marks C, Van Beak I et al. Cervical human

  36. papillomavirus infections in commercial sex workers-risk factors and behaviours. Int J STD AIDS: 2003;14(2):840-847.

  37. Choi BS, Kim O, Park MS, Kim KS, Jeong JK, Lee JS. Genital human papillomavirus genotyping by HPV oligonucleotide microarry in Korean commercial sex workers. J Med Virol

  38. 2003;71(3):440-445.

  39. World Health Organization. What is DOTS. A guide to understanding the WHO- recommended TB Control Strategy Known as DOT. Ginebra: WHO (WHOICDS/CPC/TB/99.270), 1999.

  40. Reigota RMS. A valiação do controle da tuberculose pulmonar no município de Bauru-SP implantayao do tratamento supervisionado, 1999/2000. Tesis. Botucatu (SP): Esco1a de Enfermagem de Ribeirão Preto/USP, 2001.

  41. Pinho JL, Nogueira P A. Tratamento supervisionado em tuberculose no município de Taboão da Serra, Sao Paulo 1998-1999. Bol Pneumol Sanitaria (Rio de Janeiro) 2001; 9(1): 13-18.

  42. World Health Organization.Global tuberculosis control-surveillance, planning, financing. WHO Report 2004 [monografía en internet]. Ginebra: WHO, 2004 [consultado 2004 abril 5]. Disponible en: http://www.who.intltb/publications/globalreport/2004/enlBrazil.pdf

  43. Morse D. Directly observed therapy for tuberculosis. BMJ 1996; 312: 719-720.

  44. OPS. Programas Nacionales de Control de TB. México, D.F.: Oficina Regional de la OMS. (OPS/HCP/HCT176/00), 2000.

  45. Lee E T. Statistical method for survival data analysis. Nueva York: John Wiley & Sons, 1992.

  46. Ministério da Saúde. Manual Técnico para o Controle da Tb 2002. Brasília (D.F.): Ministério da Saúde; Caderno de Atenção Básica No. 6), 2002.

  47. Frieden T, Driver C. Tuberculosis control: Past 10 years and future progress. J Tuberculosis 2003; 83 (issues 1-3):82-85.

  48. Secretaría de Salud. Dirección General de Epidemiología. Histopathological Registry of Malignant. México, D.F.: SSA, 1996.

  49. Fu YS, Reagan JW, Richart RM. Definition of precursors. Gynecol Oncol 1981;12:220-231.

  50. WHO. Infecciones genitales por papilomavirus humanos y cáncer: memorándum de una reunión de la OMS. Bol Oficina Sanit Panam 1987;65:120-137.

  51. Ludicke F, Stalberg A, Vassilakos P, Major AL, Campana A. High-and intermediate-risk human papillomavirus infection in sexually active adolescent females. J Pediatr Adolesc Gynecol 2001;14(4):171-174.

  52. Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-González CJ, Zampilpa-Mejía LG, García Cisnseros S et al. Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers frm Mexico City. Sex Transm Dis. 2001;28(3):125-130.

  53. Rodríguez-Reyes ER, Cerda-Flores RM, Solís-Rios NP, Quiñones-Pérez JM, Cortés-Gutiérrez EI. Identification and typification of the human papiloma virus in women using the “Timely Detection of Cancer” program in Durango, Mexico. Ginecol Obsted Mex. 2003;71:471-475.

  54. Mak R, Van Renterghen L, Cuvelier C. Cervical smears and human papillomavirus typing in sex workers. Sex Transm Infect 2004;80:(2)118-120.

  55. Chan R, Khoo L, Ho TH, Koh CF, Lee ILU, Yam KL et al. A comparative study of cervical cytology, colposcopy and PCR for HPV in female sex workers in Singapore. Int J STD AIDS. 2001;12(3):159-163.

  56. Tideman RL, Thompson C, Rose B, Gilmour S, Marks C, Van Beak I et al. Cervical human papillomavirus infections in commercial sex workers-risk factors and behaviours. Int J STD AIDS: 2003;14(2):840-847.

  57. Choi BS, Kim O, Park MS, Kim KS, Jeong JK, Lee JS. Genital human papillomavirus genotyping by HPV oligonucleotide microarry in Korean commercial sex workers. J Med Virol 2003;71(3):440-445.




2020     |     www.medigraphic.com